(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one

CAS: 154598-52-4

Ref. AN-AG0037PV

Información del producto

• Nombre: (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
• Sinónimos: [u'(s)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one', u'DMP 266', u'DMP-266', u'efavirenz', u'efavirenz, (R)-isomer', u'efavirenz, (S)-isomer', u'L 743,726', u'L 743726', u'L-743,726', u'L-743726', u'Stocrin', u'Sustiva', u'efavirenz', u'154598-52-4', u'Sustiva', u'Stocrin', u'DMP-266', u'DMP 266', u'(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one', u'EFV', u'UNII-JE6H2O27P8', u'HSDB 7163', u'L-743726', u'L-743,726', u'(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE', u'(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one', u'(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one', u'JE6H2O27P8', u'CHEBI:119486', u'MFCD05662344', u'NSC742403', u'L 743726', u'C14H9ClF3NO2', u'(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one', u'DSSTox_CID_26029', u'DSSTox_RID_81298', u'DSSTox_GSID_46029', u'(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one', u'2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-', u'EFZ', u'Eravirenz', u'efavirenz, (S)-isomer', u'(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one', u'(S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE', u'SMR000466351', u'Strocin (TM)', u'Sustiva (TM)', u'Sustiva (TN)', u'CAS-154598-52-4', u'Efavirenz (JAN/INN)', u'SR-01000759360', u'Efavirenz [USP:INN:BAN]', u'Efavirenzum', u'Met-SDF-1.beta. & Efavirenz', u'1ikv', u'1ikw', u'(S)-Efavirenz', u'NCGC00159337-02', u'Efavirenz, (S)', u'Efavirenz & PLGA', u'Efavirenz & IFNL1', u'Efavirenz & IFNL2', u'Efavirenz & IFNL3', u'PubChem5812', u'Efavirenz & IL-29', u'DMP-266; Efavirenz', u'Efavirenz & IL-28A', u'Efavirenz & IL-28B', u'EFV & Interleukin 29', u'EFV & Interleukin 28A', u'EFV & Interleukin 28B', u'EFV & PLGA', u'AC1L20IX', u'EFV & IFNL1', u'EFV & IFNL2', u'EFV & IFNL3', u'EFV & Interferon lambda-1', u'EFV & Interferon lambda-2', u'EFV & Interferon lambda-3', u'Efavirenz & Interleukin 29', u'SCHEMBL37762', u'Efavirenz & Interleukin 28A', u'Efavirenz & Interleukin 28B', u'MLS000759465', u'MLS001424087', u'BIDD:GT0383', u'L-743725', u'BDBM2483', u'CHEMBL223228', u'EFV & IL-28A', u'EFV & IL-28B', u'DTXSID9046029', u'Efavirenz, >=98% (HPLC)', u'CTK8E9137', u'Efavirenz & Interferon lambda-1', u'Efavirenz & Interferon lambda-2', u'Efavirenz & Interferon lambda-3', u'EFV & IL-29', u'KS-00000ZEH', u'KS-00002WWM', u'AOB2950', u'XPOQHMRABVBWPR-ZDUSSCGKSA-N', u'BCPP000245', u'HMS2051J08', u'HMS2090N16', u'HMS3393J08', u'HMS3713M14', u'Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz', u'BCP27719', u'ZINC2020233', u'Tox21_111582', u'DL-535', u'GP6354', u's4685', u'AKOS015894951', u'Efavirenz & Poly-lactide-co-glycolide', u'Tox21_111582_1', u'AB21723', u'API0002525', u'BCP9000636', u'CCG-101011', u'CS-2154', u'DB00625', u'KS-5380', u'NC00261', u'NSC-742403', u'RL01986', u'RTX-012332'], (4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one, (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one, (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one, (S)-4-(2-Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one, (S)-4-(Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one, (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one, (S)-Efavirenz, 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-, 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-, 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (S)-, Dmp 266, Efavuirenz, L 743726, Stocrin, Sustiva
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 315.6750
• Fórmula: C₁₄H₉ClF₃NO₂
• Pureza: 98%
• Color/Forma: Solid
• InChI: InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1
• Clave InChI: XPOQHMRABVBWPR-ZDUSSCGKSA-N